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ABSTRACT
OBJECTIVE: To characterize the current stage of the institutionalization of pharmaceutical 
services in Brazilian cities.
METHODS: This study is part of the Pesquisa Nacional sobre Acesso, Utilização e Promoção do Uso 
Racional de Medicamentos (PNAUM – National Survey on Access, Use and Promotion of Rational 
Use of Medicines), a cross-sectional, exploratory, and evaluative study composed by an information 
survey in a representative sample of cities, stratified by Brazilian regions. We interviewed municipal 
secretaries of health, responsible for pharmaceutical services, and pharmacists responsible for 
the dispensing of medicines. The variables selected from the interviews were grouped into five 
dimensions that defined three stages of pharmaceutical services institutionalization: incipient 
(0%-34.0%), partial (35.0%-69.0%), and advanced (70.0%-100%), estimated based on the interviewees’ 
answers. Frequencies were estimated with 95% confidence intervals. For the statistical association 
analysis, the Chi-square test was applied, with significance level of p<0.05.
RESULTS: Our results show a partial and heterogeneous process of institutionalization of 
pharmaceutical services in Brazil, and an advanced stage in formal structures, such as the 
municipal health plans and the existence of a standardized list of medicines. The analysed 
variables in the “organization, structure, and financing” dimension configured stages that range 
from partial to advanced. The management presented partial institutionalization, positively 
showing the existence of computerized system, but also disparate results regarding the autonomy 
in the management of financial resources. Indispensable items related to the structure expressed 
disparities between the regions, with statistically significant differences.
CONCLUSION: The study showed a partial and heterogeneous process of institutionalization of 
pharmaceutical services in Brazilian cities, showing regional disparities. Variables related to the 
normative aspects of institutionalization were positively highlighted in all dimensions; however, 
it is necessary to conduct new studies to evaluate the institutionalization of pharmaceutical 
services’ finalistic activities.
DESCRIPTORS: Health Manager. Pharmaceutical Services, organization & administration. 
Primary Health Care. Health Services Research. Unified Health System.
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INTRODUCTION
The trajectory of pharmaceutical services in Brazil points to advances and challenges to its 
consolidation as a State policy, which aims to provide comprehensive health care for the 
population. Evidence in the political, administrative, and social scopes indicate a gradual 
movement of institutionalization of pharmaceutical services (PS), congruous with the 
construction process of the Brazilian Unified Health System (SUS), which aims to guarantee 
the access to medicines and their rational use25,26.
The institutionalization of pharmaceutical services has been induced by the Brazilian 
Ministry of Health in recent decades. Normative and political actions affected the financing, 
structuring, and organization of PS in several operational areas of SUS. Several initiatives 
compose this process: the publishing of the National Drug Policy19, the 1st National 
Conference of Medicines and Pharmaceutical Services23, the passing of the National Policy 
of Pharmaceutical Services22, and the mandatory adoption of the Relação Nacional de 
Medicamentos Essenciais (Rename – National List of Essential Medicines), which is updated 
every two years, as a parameter to access to medicines.
The founding of the Department for Pharmaceutical Services by the Brazilian Ministry of 
Health, in 2003, was an important step in the institutionalization of PS, by endowing them 
with proper structures to conduct this policy32. The financing – essential element to support 
of the policy of access to medicines –, also leads to the institutionalization of PS on SUS. 
The specific financing ordinances for PS ensure resources from the three management 
levels for the acquisition of medicines and the structuring of PS in the cities. The Programa 
de Qualificação da Assistência Farmacêutica (Qualifar: SUS – Pharmaceutical Services 
Qualification Program)24 stands out in this process, also providing professional training and 
qualification for individuals.
The process of institutionalization requires evaluation, because formal structures 
incorporated in the level of organizations would tend to support and provide stability to a 
set of actions, for instance, those performed by PS in organizations that compose SUS, in its 
several management and health care levels. This study, thus, corroborates Oliver’s definition 
of institutionalized actions as the ones that tend to be enduring, socially accepted, resistant 
to change and not directly dependent on rewards or monitoring of their permanence27.
In a study that aims to develop a proposal for monitoring and normative evaluation of 
basic PS, in the state of Mato Grosso, Freitas13 considered the institutionalization of PS as a 
transversal component that covers its logistical cycle and extends itself to the actions that 
guarantee the sustainability of the area, such as the formalization in the organization chart 
of the Municipal Secretariat of Health, the legalization of the municipal pharmaceutical 
network, and the participation of deliberative instances of health.
By defending the institutionalization of health evaluation, Contrandiopoulos8 states that 
the institutionalization of this practice will only take place if the evaluation is incorporated 
to the health care organizations’ routine, so as to integrate the planning and management 
process of policies and programs. 
Studies regarding the institutionalization of PS are scarce. An experience report regarding the 
medicine selection in public hospitals in the state of Sergipe highlighted the importance of the 
theoretical/methodological framework of the Strategic Situational Management to implement 
and consolidate the Comissões de Farmácia e Terapêutica (PTC – Pharmacy and Therapeutics 
Committees), an essential tool in the institutionalization of the medicine selection process32.
Pharmaceutical services, as a transversal component in SUS – with the medicine as a 
strategic input –, induces other sectoral policies, especially those of scientific and technologic 
development20. Their institutionalization, in the course of the decentralization of health 
actions, proved itself a necessary process to improve the health system performance as a 
whole in the search for the universality and integrality of primary health care18.
3s
Institutionalization of pharmaceutical services in Brazil Souza GS et al.
https://doi.org/10.11606/S1518-8787.2017051007135
The institutionalization processes have some common elements characterizing them, 
whether in the institutionalization trajectory of policies, programs, or of specific practices 
within the organizations. With rules and the adoption of formal structures of policies, 
programs, and practices, standardizations lead to the internalization of values, habits, and 
cultures that are incorporated to the organizations routine2,34.
The problematization of the institutionalization process of PS requires the consideration of its 
transversal and systemic nature, considering the internalization of procedures and routines in 
the organizations that compose the several operational areas of SUS. It encompasses a group 
of planning and managing activities of PS and, also, of practices that require management and 
technical expertise that entail the selection, scheduling, acquisition, and dispensing of medicines 
and of therapeutic planning activities of medical nature, aiming the rational use of medicines.
Such studies contribute to confirm the performance of governmental actions in the 
implementation and sustainability of PS policies. This study aimed to characterize the current 
stage of the PS institutionalization in the municipal health care systems in Brazil, seeking to 
contribute with the discussion regarding the implementation of PS policies.
METHODS
This article is part of the Pesquisa Nacional sobre Acesso, Utilização e Promoção do Uso 
Racional de Medicamentos – Serviços, 2015 (PNAUM – National Survey on Access, Use and 
Promotion of Rational Use of Medicines –Services, 2015), which aims to characterize the 
organization of PS in SUS primary health care, aiming to promote the access and rational use 
of medicines, as well as to identify and discuss the factors that interfere in the consolidation 
of PS in the cities.
PNAUM is a cross-sectional, exploratory, and evaluative study composed by an information 
survey in a sample of primary health care services of cities that represent the Brazilian regions, 
with direct observation of PS and interviews, and with a planned sample of 600 cities, carried 
out between 2014 and 2015. From these 600 cities, 300 were selected for an enquiry about 
health services, with face-to-face interviews with users, physicians, those responsible for 
dispensing of medicines, and direct observation of structural aspects.
We selected 27 capitals and 0.5% of the largest cities of each region, and we chose the 
remaining cities by lot. The estimation of the size of the representative sample considered 
three levels: cities, medicine dispensing services, and users. The sampling process aimed to 
maximize the randomization. The interviews were conducted by trained professionals, with 
the application of a structured questionnaire for each group of interviewees: face-to-face 
interview with physicians, those responsible for dispensing of medicines, and users; and 
phone interview with the professionals responsible for pharmaceutical services (RPS) 
and the municipal secretaries of health (SMS). More details can be found in the article 
by Álvares et al.1
This article used data from the interviews with SMS, those RPS, and those responsible for 
dispensing of medicines; in this scenario, we only used the data of pharmacists, since the 
analysed variable could not be applied to the other professionals. Regarding the SMS, the 
data were used only for Brazil because the percentage of interviewees did not represent each 
region. Concerning the RPS, the percentage of interviewees was representative, allowing the 
data to be used to characterize the institutionalization in the five regions as well as in Brazil.
The development of an operational concept was required for the institutionalization of PS 
in the cities, to express the necessary dimensions to the characterization of its stage.
For the analysis, we defined the institutionalization of PS in the cities as a social, political, 
and technical/administrative process that expresses itself in the creation of formal structures 
in the municipal health care systems, in the organization, structuring, and financing of PS, 
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in management tools, in the development of practices and activities related to PS, in social 
participation and control, aiming to promote a comprehensive health care.
The operational elements were organized into five dimensions, with the selected variables, 
aiming to characterize the PS institutionalization in the cities (Table 1). 
In the data analysis for the characterization of the PS institutionalization, concerning 
the PTC, we only considered answers that confirmed the existence of this structure, and 
references to implementation processes were disregarded. Concerning the autonomy of 
the PS coordination in the management of financial resources (management tool), the 
answers of total or partial autonomy were considered as “yes.” In the variable Conselho 
Municipal de Saúde (CMS – Municipal Health Council), which discusses and deliberates over 
pharmaceutical services, the answers “always” and “repeatedly” were considered affirmatives.
Based on the percentage obtained from the means positive answer for each variable, we 
defined three stages of the PS institutionalization: incipient (0-34.0%), partial (35.0%-69.0%), 
and advanced (70.0%-100%). The data were analysed with the SPSS® software, version 21, in the 
analysis module for complex samples. For the statistical association analysis, we applied the 
Chi-square test, with significance level of p<0.05.
PNAUM was approved by the National Research Ethics Committee (Opinion 398.131/2013). 
The objectives of the research were explained to the interviewees, and they signed the 
informed consent form.
Table 1. Dimensions and variables selected for the characterization of the pharmaceutical services 
institutionalization in the cities. National Survey on Access, Use and Promotion of Rational Use of 
Medicines – Services, 2015. 
Dimension of PS Selected Variables
Formal structures
The coordination of PS is present in the organization chart of the Municipal 
Secretariat of Health
PS are present in the Municipal Health Plan
Existence of Comissões de Farmácia e Terapêutica (PTC – Pharmacy and Therapeutics 
Committees)
Existence of standardized list of medicines




Expenditure with the structuring of municipal PS
Total application of the funds for PS
The professional responsible for PS is a pharmacist
Management tools
The coordination of PS has total or partial autonomy in the management of financial 
resources
Existence of SOP for reception, storage, dispensing, and delivery of medicines
Existence of computerized system for PS management
Provision of information on the medicine delivery locations to the population
Existence of training for PS professionals
Practices and activities 
pertaining to PS
Performance of clinical activities
Social participation 
and control
Existence of mechanisms to receive criticism and suggestions from workers
Existence of mechanisms to receive criticism and suggestion from users
Municipal Health Council (CMS) discusses and deliberates about PS
Existence of accountability of PS in the Municipal Health Council (CMS)
Users participate in the decisions related to the PS management
PS: pharmaceutical services; SOP: standard operating procedures
5s
Institutionalization of pharmaceutical services in Brazil Souza GS et al.
https://doi.org/10.11606/S1518-8787.2017051007135
RESULTS
We interviewed 369 SMS (61.5% of the estimated sample); 507 RPS (84.5% of the estimated 
sample); and 1,139 professionals responsible for dispensing of medicines (83.6% of the 
estimated sample). 32.7% of the aforementioned were pharmacists.
Table 2 presents the characteristics of PS institutionalization in Brazil, according to the 
interviews with SMS and those RPS. Table 3 shows the characteristics of PS institutionalization 
in Brazil and its regions, according to those RPS. In general, the Southeast region showed 
more positive results and the North, more negative results.
In the “formal structures” dimension (Table 2), of the five variables analysed, three had 
means above 80.0%: PS in the Municipal Health Plans (PMS); existence of a standardized list 
of medicines; and PS coordination in the organization chart of the municipal secretariats of 
health, with percentage differences between the informants.
Regarding the presence of PS in the PMS and the existence of a standardized list of medicines, 
the distribution in the regions presented high percentages and statistically significant 
differences (Table 3). In Brazil, PTC have a low percentage, according to those RPS (13.2%) 
and SMS (10.7%) (Table 2). This result contrasts with the high percentage of cities with 
standardized list of medicines, which may indicate the adoption of lists that are available 
on SUS, such as Rename from the Brazilian Ministry of Health.
Regarding the existence of Comissão Permanente de Licitação (CPL – Permanent Bidding 
Committee) exclusively for the acquisition of medicines, Brazil presented a percentage that 
ranges from 37.7% to 40.0%, according to those RPS and SMS, respectively (Table 2). In the 
Brazilian regions, the lowest percentage was found in the Northeast (Table 3).
Table 2. Pharmaceutical services institutionalization in Brazil*, according to those responsible for 
pharmaceutical services (n = 507) and municipal secretary of health (n = 369). National Survey on 
Access, Use and Promotion of Rational Use of Medicines – Services, 2015.
Dimension/variable RPS% (95%CI) SMS% (95%CI)
Formal structures
The coordination of PS is present in the organization chart 82.7 (78.3–86.4) 91.7 (87.7–94.5)
PS are present in the Municipal Health Plan 92.3 (89.1–94.6) 97.2 (94.3–98.7)
Existence of Comissão de Farmácia e Terapêutica 
(PTC – Pharmacy and Therapeutic Committee)
13.2 (10.1–17.1) 10.7 (7.4–15.2)
Existence of standardized list of medicines 85.9 (82.1–89.0) 85.5 (80.9–89.1)
Existence of exclusive CPL for medicine acquisition 37.7 (32.6–43.0) 40.0 (34.0–46.3)
Organization, structure, and financing
Expenditure with PS structuring 54.8 (49.1–60.5) 67.3 (61.1–73.0)
Total application of funds 86.4 (81.1–90.4) 97.1 (94.1–98.6)
Management tools
The coordination of PS has total or partial autonomy in the 
management of financial resources
57.9 (48.7–68.0) 68.3 (62.3–73.8)
Existence of computerized system for PS management 70.8 (66.0–75.1) 74.7 (69.2–79.5)
Existence of training for PS professionals 11.9 (8.6–16.2) 37.7 (31.8–44.0)
Social participation and control
Existence of mechanisms to receive criticism and 
suggestions from workers about PS
32.8 (27.8–38.3) 63.0 (56.8–68.8)
Existence of mechanisms to receive criticism and 
suggestions from users about PS
40.7 (35.2–46.4) 68.2 (62.2–73.7)
Municipal Health Council (CMS) discusses and deliberates 
always or repeatedly about PS
42.3 (35.9–48.8) 53.7 (47.3–59.9)
Existence of accountability of PS in the CMS 82.8 (76.4–87.7) 93.5 (89.4–96.1)
RPS: those responsible for pharmaceutical services; SMS: municipal secretary of health; PS: pharmaceutical 
services; CPL: Permanent Bidding Committee; CMS: Municipal Health Council.
*Institutionalization stages: incipient – 0 to 34.0%; partial – 35.0% to 69.0%; advanced – 70.0% to 100.0%
Source: PNAUM – Services, 2015.
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In the organizational, structural, and financing dimensions, the analysed variables (Table 2) 
showed the stage of PS institutionalization is between partial and advanced. Table 3 highlights 
the high percentage of pharmacists responsible for PS in Brazilian regions, the Northeast 
with the lowest percentage (83.7%), and statistically significant differences. However, PNAUM 
points out that, in Brazil, a little more than 40.0% of pharmacies/medicine dispensing units 
has a pharmacy technician in charge9.
Table 3. Pharmaceutical services institutionalizationa in Brazil, according to those responsible for the pharmaceutical services (n = 507). 
National Survey on Access, Use and Promotion of Rational Use of Medicines – Services, 2015.
Dimension/variable
Regions
North Northeast Midwest Southeast South Brazil
% (IC95%) % (IC95%) % (IC95%) % (IC95%) % (IC95%) % (IC95%)
Formal structures
The coordination of PS is present in 
the organizational chart
71.8 (61.0–80.6) 82.5 (72.2–89.6) 85.8 (76.5–91.8) 87.3 (78.5–92.8) 79.2 (69.6–86.3) 82.7 (78.3–86.4)
PS is present in the Municipal 
Health Planb
88.0 (78.4–93.7) 100.0 (100.0–100.0) 91.3 (82.7–95.8) 88.8 (79.8–94.1) 88.3 (80.2–93.4) 92.3 (89.1–94.6)
Existence of Pharmacy and 
Therapeutic Committee
11.4 (6.4–19.5) 10.2 (5.1–19.1) 14.7 (8.9–23.5) 14.1 (8.3–22.8) 15.9 (10.0–24.3) 13.2 (10.1–17.1)
Existence of standardized list of 
medicinesb
70.6 (60.3–79.1) 92.0 (83.2–96.4) 83.7 (74.7–90.0) 86.9 (78.3–92.4) 82.9 (74.1–89.1) 85.9 (82.1–89.0)
Existence of exclusive CPL for 
medicine acquisition
41.4 (31.2–52.4) 33.6 (23.5–45.6) 49.0 (38.5–59.5) 38.1 (28.5–48.7) 36.9 (27.8–46.9) 37.7 (32.6–43.0)
Organization, structure, and financing
Expenditure with PS structuring 44.0 (32.9–55.8) 62.5 (50.5–73.2) 58.5 (47.0–69.1) 44.3 (33.0–56.2) 59.1 (48.4–69.0) 54.8 (49.1–60.5)
Total application of funds 73.7 (59.8–84.1) 80.5 (67.0–89.4) 85.3 (70.8–93.3) 90.2 (79.8–95.5) 92.7 (83.0–97.0) 86.4 (81.1–90.4)
The professional responsible for PS is 
a pharmacistb
86.6 (77.7–92.2) 83.7 (73.8–90.3) 88.1 (80.0–93.2) 94.8 (88.0–97.8) 95.0 (88.6–97.9) 90.3 (86.8–93.0)
Management tools
The coordination of PS has total or 
partial autonomy in the management 
of financial resources
35.8 (26.1–46.8) 53.7 (42.3–64.6) 50.4 (40.1–60.7) 62.6 (51.8–72.3) 66.6 (56.6–75.3) 57.9 (52.4–63.1)
Existence of computerized system for 
PS managementb
40.1 (30.5–50.5) 61.2 (50.0–71.4) 53.5 (43.5–63.3) 78.7 (69.2–85.8) 88.8 (80.9–93.7) 70.8 (66.0–75.1)
Existence of SOP for medicine 
receptionb
62.0 (51.0–71.9) 68.7 (57.0–78.4) 66.4 (55.8–75.6) 78.8 (69.0–86.1) 58.7 (48.7–68.1) 68.9 (63.8–73.5)
Existence of SOP for storageb 60.8 (49.7–70.8) 72.0 (60.5–81.1) 70.2 (59.8–78.9) 80.5 (71.1–87.4) 60.9 (50.8–70.1) 71.2 (66.2–75.6)
Existence of SOP for dispensingb 53.3 (42.4–63.8) 67.2 (55.5–77.2) 68.8 (58.3–77.6) 77.2 (67.6–84.7) 56.8 (46.7–66.3) 67.1 (62.0–71.9)
Existence of SOP for deliveryb 55.0 (44.1–65.5) 67.1 (55.4–77.0) 71.9 (61.5–80.4) 83.4 (74.2–89.7) 57.7 (47.7–67.1) 69.6 (64.6–74.1)
Existence of training for PS 
professionals
10.4 (5.3–19.2) 11.6 (5.6–22.4) 14.8 (8.4–24.9) 13.5 (7.6–22.8) 9.5 (4.8–17.8) 11.9 (8.6–16.2)
Those RPS participate in planning 
health actions of different 
technical areas
34.5 (24.8–45.7) 24.9 (15.1–38.0) 30.9 (21.2–42.5) 22.5 (14.7–33.0) 31.5 (22.2–42.4) 26.9 (22.1–32.3)
Provision of information on the 
standardized medicine delivery 
locations to the population
50.6 (39.9–61.2) 43.4 (31.5–56.0) 42.1 (31.4–53.6) 35.7 (26.1–46.7) 39.5 (29.5–50.4) 40.5 (35.0–46.2)
Social participation and control
Existence of mechanisms to receive 
criticism and suggestions from 
workers about PS
29.2 (20.3–40.0) 24.2 (15.0–36.8) 42.2 (31.6–53.6) 35.9 (26.2–46.9) 36.5 (26.9–47.3) 32.8 (27.8–38.3)
Existence of mechanisms to receive 
criticism and suggestions from users 
abour PS
43.6 (33.1–54.7) 32.5 (21.9–45.3) 42.2 (31.6–53.6) 43.1 (32.6–54.2) 45.6 (35.2–56.4) 40.7 (35.2–46.4)
Municipal Health Council discusses 
and deliberates always or repeatedly 
about PS
34.0 (23.2–46.8) 30.2 (18.1–45.8) 39.0 (27.6–51.8) 31.7 (21.4–44.1) 36.8 (25.9–49.2) 33.4 (27.5–39.8)
Accountability of PS in the CMS 81.4 (66.9–90.5) 89.4 (73.2–96.3) 83.8 (70.5–91.8) 77.5 (63.7–87.1) 83.8 (70.8–91.6) 82.8 (76.4–87.7)
CPL: Permanent Bidding Committee; PS: pharmaceutical services; SOP: standard operating procedures; CMS: Municipal Health Council 
a Institutionalization stages: incipient – 0 to 34.0%; partial – 35.0% to 69.0%; advanced – 70.0% to 100.0%
b p < 0,05
Source: PNAUM – Services, 2015.
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Regarding the financing of PS in Brazil, 86.4% of those RPS claimed they applied the complete 
value of the municipal financing funds; among SMS, the percentage was 97.1% (Table 2). These 
percentages varied between regions, without statistically significant differences (Table 3).
Regarding the financial resources expenditure AF structuring, 54.8% of the RAF stated that 
these expenditures occurred. For the SMS this percentage was 67.3% (Table 2). The North and 
South regions were below the national the mean (Table 3), with no statistically significant 
differences between the regions.
The “management tools” dimension presents a partial institutionalization stage in Brazil. 
In general, the region that most stood out was the Southeast, with advanced stages in five 
out of the nine analysed variables, contrasting with the North region (Table 3).
In Brazil, regarding the autonomy of the management of financing resources by the PS 
coordination, we found discrepancy between those RPS (57.9%) and SMS (68.3%) (Table 2). 
In this component, the regions presented great differences between themselves: 35.8% in 
the North and 66.6% in the South, without statistically significant difference.
Regarding the existence of a computerized system for pharmaceutical services management, 
the percentages in Brazil were above 70.0%, according to both interviewees (Table 2). 
However, we found great differences between the regions: 88.8% in the South and 40.1% in 
the North (Table 3), with statistically significant differences. Among the RPS who confirmed 
the existence of a computerized system in PS management, only 16.3% stated they use the 
Hórus System, made available and recommended by the Brazilian Ministry of Health.
The standard operating procedures (SOP) for the receiving, storage, dispensing, and delivery 
of medicines (Table 3) are above 67.0% in Brazil, with statistically significant differences 
between the regions, highlighting the Southeast in the advanced stage.
PNAUM showed a concerning situation about the qualification of the professionals working 
in PS in Brazil. Only 11.9% of those RPS affirm the existence of qualification/training for 
the professionals of pharmaceutical services, and this percentage rises to 37.7% of the 
SMS (Table 2).
Those RPS participated slightly in the planning process of the other technical areas of health, 
confirmed by 26.9% of these agents, without statistically significant difference (Table 3).
In Brazil, only 40.5% of those RPS provided information to the population about the locations 
of medicine delivery. The differences between the regions, however, presented no statistical 
significance (Table 3).
In the “social participation and control” dimension, PNAUM showed that, in three out of the 
four analysed variables, the institutionalization is incipient in Brazil, according to those RPS 
and partial, according to SMS (Table 2). The achieved percentages of the variable regarding 
the accountability of PS in the CMS were high both for those RPS (82.8%) and SMS (93.5%). 
However, the CMS discusses and deliberates always and repeatedly about PS for 42.3% of 
those RPS and 53.7% of SMS.
Concerning the permeability of PS for users, there is a great difference between the agents: 
68.2% of SMS and 40.7% of those RPS affirm the existence of mechanisms to receive criticism 
and suggestions about PS. Regarding the mechanisms to receive criticism and suggestions 
from health professionals, 63.0% of SMS and 32.8% of those RPS answered positively 
(Table 2). The Midwest and the South achieved better results, without statistically significant 
differences between the regions (Table 3).
In the “PS practices” dimension, only pharmacists responsible for the medicine delivery 
answered the questions about the variable regarding the performance of clinical activities. 
The institutionalization stage was incipient because only 21.3% of pharmacists stated they 
perform these activities.
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DISCUSSION
Our study showed a heterogeneous scenario of the PS institutionalization in the Brazilian 
regions. The “formal structure” dimension reached the highest score. Portela et al.31 consider 
that the presence of PS in the organization chart of the SMS and the existence of their own 
organizational structure characterize their institutionalization. However, formal structure 
and regulations compose a dimension, and they are only the initial steps of a policy 
institutionalization process.
The research showed that the PS formal structures contain variables that indicate the 
institutionalization in the advanced stage and others in partial or incipient stages, such as 
the low rate of PTC.
The formalization of PS in the organization chart validates its operation before the public 
areas, making it visible to the population and the remaining health sectors7. The low rate 
of PTC corroborates the results of Marques & Zucchi17, which point to these committees’ 
structural weaknesses in Brazil, structures that are important to the selection, standardizing, 
and rational use of medicines and that should be adjusted to the national and local 
situations17. However, the difficulties of Brazilian cities in the health care system organization 
and structuring may hinder the structuring of these committees16.
The medicine selection and acquisition are part of the logistic cycle of PS. The selection 
must result in a standardized list that guides the acquisition, which, in turn, takes place 
in the medicine purchase process in suitable quantity and quality, aiming to lower the 
costs and the supply system regular operation19. The absence of an exclusive CPL may 
hinder the expenditure of financial resources destined to the medicine acquisition 
because of the possibility of this item’s lack of priority compared with acquisitions from 
other municipal administrations.
The “PS organization, structure, and financing” dimension shows the most unfavourable 
percentages in the variable concerning the expenses with the structuring of services. The lack 
of proper structuring of PS may negatively affect the working conditions and medicine 
sanitary condition, with possible losses and risks in their use10.
Despite the difference between agents regarding the use of PS funds, these results stand 
close to a research about Paraiba cities6. In that study, after ten years of the enactment 
of PNAF, the investment in the structuring of Brazilian public pharmacies was still low 
regarding medicine storage conditions35, and its results corroborated the research of the 
Pan American Health Organization21, in which only 61.0% of the pharmacies had suitable 
conditions for the medicine preservation in warehouses and 60.0% in the municipal 
pharmaceutical supply centers28.
The tripartite financing for medicine acquisition has been important to the decentralization 
of PS, and it has grown since the establishment of specific financing for its structuring21. 
However, the increase in financing in the last years was insufficient to qualify the medicine 
acquisition by the public agents in Brazil, which is a challenge for the PS management to 
improve expenditure in the area. The lack of autonomy of the coordination of PS regarding the 
financial resources, which those RPS and SMS show with significant percentages, may explain 
part of the difficulties regarding the pharmaceutical services structuring and qualification.
Although in Brazil the percentages of those who claim having a computerized system 
are above 70.0%, we found great differences between the regions, with inequalities in the 
infrastructure and logistics of the health services. The low application of Sistema Hórus 
(Hórus System) attests to this, with evidences that this system strengthens the control and 
the monitoring of medicine use11.
The high percentages of those RPS that confirm the existence of several SOP stand out. They 
are important elements to the organization and quality of work, because they describe the 
9s
Institutionalization of pharmaceutical services in Brazil Souza GS et al.
https://doi.org/10.11606/S1518-8787.2017051007135
sequence of every crucial step that should be taken to ensure the expected result of the 
task5. Similarly, medical protocols and therapeutic guidelines are tools that contribute to 
the adequate use of medicines33.
The presence of qualified professionals is fundamental; PS are a multidisciplinary and dynamic 
process, with actions that aim to provide access, quality, and rational use of medicines14. Professional 
training, mainly that of the pharmacist, is necessary to the structuring of PS processes, from the 
technical to the administrative issues, related to the logistic cycle and pharmaceutical care14.
PNAUM showed a management process of PS that is still restricted to the sector, which 
may compromise its transversality in the support to health care networks and their 
administration18. The integration of professions is indispensable to the development of health 
practices in a comprehensive approach29. Teamwork should be in the frontline of strategies 
to change the health care models, before the extremely complex sociocultural and economic 
contexts that are increasingly more dynamic30.
The “social participation and control” dimension has a significant role in the institutionalization 
process of public policies, especially in the State actions and public resources destination, 
aiming to resist the reduction of social policies, the privatization, and the commodification of 
the services9. Health Councils have become the most comprehensive networks of participatory 
instances of the country12. The social control instances are not mechanisms above society and 
immune to conflict of interest and disputes focused on distinct societal projects4. PNAUM shows 
that social control is still limited in PS, despite of conflict of interest and of the symbolic and 
economic power that permeates medicines, which are strategic elements in this field of health.
Access to medicines is in the population’s interest, thus they have increasingly sought the judicial 
system to ensure this right3,6,15.However, PNAUM shows that CMS are instances insufficiently 
sought for the right to PS. The process of social participation and control show weaknesses 
regarding PS in Brazil. Nevertheless, the high percentages for the variable of accountability of PS 
in the CMS stand out, which leads us to believe that legal obligations affect this type of result.
In all variables of the institutionalization of PS, the answers of SMS presented higher 
percentages compared with the answers of those RPS, except for the existence of PTC. SMS 
may express a more optimistic perspective because they have the role of administrators of 
the municipal health policies. However, it was not possible to deepen the analysis of these 
differences, which is one of the study’s limitations as an exploratory research. This constitutes 
an outline for future studies.
Our results allowed us to conclude that the PS institutionalization process in the municipal 
health care systems is still partial and heterogeneous in the different regions of Brazil. 
We observed more advances in formal structures, since they are necessary conditions to 
the beginning of the institutionalization process of PS policies.
In general, variables related to normative aspects scored higher, except in finalistic activities, 
in the integration with other technical areas, and in the social participation and control. 
The complete institutionalization of PS as a systemic and permanent process presupposes 
that the finalistic activities of PS are disseminated in the health services.
The organization, structure, and financing variables reached a high score. These are 
conditioning results to the institutionalization and sustainability of PS policies on SUS, 
which relies on a model of practices consistent with the comprehensiveness of health care. 
The consolidation of a public policy takes place when society recognizes it as a right and 
permanent action of the State. However, according to findings related to social participation 
and control, the PS policies in Brazil have yet to reach this position. 
We did not find researches concerning the PS institutionalization in municipal health 
care systems in Brazil to make comparisons, which was another limitation of this study. 
Nevertheless, we were able to point indicators and subsidies for further evaluations. With 
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PNAUM, we concluded that PS institutionalization in the municipal scope is an ongoing 
process that already presents important advances, although several aspects are insufficiently 
consolidated to resist the restrictive political contingencies of the right to health.
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